Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations

Published:2016-01 Issue: Volume:91 Page:23-28
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tissot Claire,Couraud Sébastien,Tanguy Ronan,Bringuier Pierre-Paul,Girard Nicolas,Souquet Pierre-Jean

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. New targetable oncogenes in non-small-cell lung cancer;Oxnard;J. Clin. Oncol.,2013

2. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol.,2011

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N. Engl. J. Med.,2009

4. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N. Engl. J. Med.,2013

5. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capture of circulating metastatic cancer cell clusters from lung cancer patients can reveal unique genomic profiles and potential anti-metastatic molecular targets: A proof-of-concept study;PLOS ONE;2024-07-31

2. Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives;International Journal of Cancer;2024-07-03

3. Pathways and targeting avenues of BRAF in non-small cell lung cancer;Expert Opinion on Therapeutic Targets;2024-07-02

4. A large‐scale, multicenter characterization of BRAF G469V/A‐mutant non‐small cell lung cancer;Cancer Medicine;2024-05

5. Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience;FUTURE ONCOL;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3